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PreviewsConnecting Mitochondria
and Innate Immunity
Viral infection results in the activation of multiple sig-
naling pathways, but how these pathways are coordi-
nated remains a mystery. Two studies, one published
in this issue of Cell (Seth et al., 2005) and the other in
Molecular Cell (Xu et al., 2005), identify a new intracel-
lular signaling protein that is required for activating
type I interferon expression in response to viral infec-
tion. In addition, Seth et al. (2005) show that the func-
tion of this protein, which they call MAVS, requires
that it be localized to the mitochondria. This observa-
tion establishes an unexpected link between innate
immunity and an organelle with evolutionary origins
in aerobic bacteria.
Metazoan organisms have evolved mechanisms for
sensing the presence of infectious microorganisms and
for mounting a rapid antimicrobial defense. Viral infec-
tion is typically detected through the presence of viral
replication intermediates, such as double-stranded RNA
(dsRNA), that are detected by two signaling pathways.
Extracellular viral dsRNA is recognized by the toll-like
receptor 3 (TLR3), whereas intracellular viral dsRNA is
detected by two recently characterized RNA helicases,
RIG-I and/or Mda5 (Yoneyama et al., 2004). Activation
of either pathway triggers production of type I in-
terferon (IFN), which orchestrates both the rapid re-
sponse and long-term resistance to viral infection.
The identification of a new protein in the RIG-I path-
way represents an exciting advance (Seth et al., 2005;
Xu et al., 2005). This protein, alternately named MAVS/
VISA by two independent groups, operates down-
stream of RIG-I and regulates critical pathways in pro-
moting expression of IFN-β (see Figure 1). Seth et al.
(2005) also report the unexpected finding that MAVS is
localized in mitochondria, and that this localization is
required for its function. MAVS, therefore, provides the
first link between mitochondria and the innate immune
defense system.
RIG-I contains an RNA helicase domain that binds to
dsRNA and two amino-terminal CARD protein interac-
tion domains that interact with the CARD domains of other
proteins required for downstream signaling events. Like
RIG-I, MAVS also has an amino-terminal CARD domain,
suggesting the possibility that MAVS might be a RIG-I
adaptor protein. Both Seth et al. and Xu et al. detect
binding between RIG-I and MAVS when these proteins
are overexpressed in cultured cells. Xu et al. addition-
ally present evidence that the endogenous versions of
these proteins also interact with each other. Moreover,
an intact CARD domain is necessary for the antiviral
function of MAVS.
The extracellular and intracellular dsRNA sensors ac-
tivate distinct signal transduction pathways, yet they both
lead to the coordinated activation of the same transcrip-
tion factors: ATF2/cJun, IRF3 and -7, and NF-κB (see Fig-ure 1). Together these transcription factors form a multi-
protein enhancer complex (enhanceosome) upstream
of the type I IFN-β promoter that drives expression of
the IFN-b gene (Maniatis et al., 1998). The IFNs bind to
specific cell-surface receptors and thereby activate the
JAK-STAT signaling pathway, switching on a battery of
antiviral genes (Stark et al., 1998). A central question in
type I interferon induction is how the activation of dis-
tinct signaling pathways is coordinated.
Evidence from the two new studies places MAVS up-
stream of multiple elements in the viral response path-
way (see Figure 1), including the IκB kinase (IKK α/β/γ)
complex (which regulates NF-κB) and the “noncanoni-
cal” kinases TBK1 and IKK. In this way, MAVS func-
tions as a critical link between viral detection by RIG-I
and the downstream signaling events leading to in-
terferon production. Until these reports, the mechanism
by which RIG-I coordinates the activation of the signal-
ing pathways necessary for IFN-β expression was un-
known.
In uninfected cells, the transcription factor NF-κB is
localized in the cytoplasm where it is bound to the in-
hibitor protein IκB. Virus infection leads to the activa-
tion of the IκB kinase complex (IKK α/β/γ), which phos-
phorylates IκB (see Figure 1). This phosphorylation
marks IκB for ubiquitination and subsequent degrada-
tion by the proteasome (Chen, 2005). NF-κB then trans-
locates to the nucleus and binds to the enhancer of the
IFN-b gene.
One of the key signaling proteins in the NF-κB pathway
is TRAF6, an essential upstream regulator of the IKK
complex. MAVS binds to TRAF6 in overexpression experi-
ments and in a yeast two-hybrid screen (Seth et al., 2005;
Xu et al., 2005), and endogenous MAVS also interacts
with TRAF6 (Xu et al., 2005). Signal-induced polyubiquiti-
nation of TRAF6 (by the E1 ligase and UBC13/UEV1A)
is known to promote its recruitment to a complex con-
taining the TAK1 kinase and TAB2 adaptor protein (see
Figure 1). Activated TAK1 then phosphorylates and acti-
vates both the IKK complex as well as the stress-acti-
vated kinase cascade (Chen, 2005). Consistent with a
role for MAVS in IKK signaling, Seth et al. and Xu et al.
demonstrate that MAVS induces activation of NF-κB,
and up-regulates IFN-b gene expression. Previous work
also showed that MAVS activates an NF-κB-dependent
reporter construct in overexpression experiments in
cultured cells (Matsuda et al., 2003). Using RNA inter-
ference to block MAVS expression, Seth et al. and Xu
et al. show that MAVS is required for both virus-induced
and RIG-I-induced expression of IFN-b. Moreover,
MAVS contains two TRAF6 binding motifs, both of
which are necessary for maximal activation of an NF-
κB reporter gene.
In a different branch of the pathway downstream of
RIG-I, MAVS also induces activation of the transcription
factor IRF3, a substrate for TBK1 (see Figure 1). Upon
viral infection, phosphorylation of IRF3 and IRF7 by the
“noncanonical” kinases TBK1 and IKK leads to the di-
merization and translocation of the IRF proteins to the
nucleus (Levy and Marie, 2004). Coimmunoprecipitation
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646Figure 1. Viral Infection Results in the Activation of Multiple
Pathways
The MAVS protein coordinates several signaling pathways required
for activation of the IFN-b gene in response to virus infection. The
MAVS protein, localized in mitochondria, is a key intermediate in
the pathways that link the intracellular detection of virus by RIG-I
with downstream signaling events. MAVS binds to TRAF6. Signal-
induced polyubiquitination of TRAF6 (by the E1 ligase and UBC13/
UEV1A) is known to promote its recruitment to a complex contain-
ing the TAK1 kinase and TAB2 adaptor protein. Activated TAK1 then
phosphorylates and activates both the IKK complex as well as the
stress-activated kinase cascade (Chen, 2005). The stress-activated
kinase cascade leads to the induction of the transcription factors
ATF2/cJun. The phosphorylation of IκB by the IKK complex marks
IκB for ubiquitination and subsequent degradation by the protea-
some (Chen, 2005). NF-κB then translocates to the nucleus and
binds to the enhancer for the IFN-b gene. In addition, phosphoryla-
tion of IRF3 and IRF7 by the “noncanonical” kinases TBK1 and
IKK downstream of the TRAF2 complex leads to the dimerization
and translocation of the IRF proteins to the nucleus (Levy and Ma-
rie, 2004). The coordination of these pathways leads to assembly of
a multiprotein enhancer complex, the enhanceosome, which drives
expression of the IFN-b gene (Maniatis et al., 1998).
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Mxperiments suggest that MAVS interacts with TBK1
nd recruits endogenous IRF3 in a virus-inducible man-
er (Xu et al., 2005).
In addition to identifying a key component in the
IG-I signaling pathway, Seth et al. used confocal mi-
roscopy and subcellular fractionation techniques to
how that MAVS is located in mitochondria. They also
dentify a carboxy-terminal mitochondrial transmem-
rane domain in MAVS. Deletion of this domain or re-
lacement with sequences that localize MAVS to other
embrane compartments leads to its inactivation. Ad-
itional fractionation studies reveal that MAVS is ini-
ially present in the outer mitochondrial membrane but
oves into a detergent-resistant mitochondrial fraction
pon viral infection of the cell. These interesting results
uggest an unexpected, mitochondria-dependent mech-
nism for virus-induced activation of IFN-b gene expres-
ion. This provides yet another example of the symbi-
tic relationship that evolved during the genesis of
ukaryotic cells between the precursor of the eukary-
tic cell and the aerobic bacterial precursor of mito-
hondria.
There are some notable differences between the Seth
t al. and Xu et al. studies on MAVS/VISA. For instance,
u et al. show that MAVS fails to activate NF-κB in the
bsence of TRAF6. In contrast, Seth et al. report that
iral induction of the endogenous IFN-b gene occurs
ormally in cells deficient in TRAF6, and that a MAVS
rotein lacking the TRAF6 binding domain is still capa-
le of inducing IFN-β. However, it is possible that an-
ther protein, such as TRAF2, compensates for the lack
f TRAF6 in the induction of IFN-β (see Figure 1). In-
eed, the TRAF2 binding site in MAVS contributes to
F-κB activation (Xu et al., 2005). TRAF2 associates
ith both RIP1 and FADD, additional components im-
licated in virus-induced IFN-β production (Balachan-
ran et al., 2004). However, Seth et al. were unable to
how an interaction between MAVS and RIP1 or FADD
nd report that RIP1 is not required for virus-induced
FN-β production. Clearly, these inconsistencies must
e resolved and, in the absence of unequivocal proof
hat known signaling intermediates link MAVS to down-
tream kinases, alternative pathways must be consid-
red. An interesting possibility is that MAVS signals
hrough mitochondrial proteins, initiating a cascade of
vents ultimately leading to the induction of IFN-β.
Another unresolved question is whether MAVS also
cts in the response to extracellular dsRNAs. In this
athway, TLR3 receptors bind to dsRNAs and recruit
he TIR adaptor protein, TRIF (Akira and Takeda, 2004).
RIF then recruits additional signaling components
RIP1, TBK1, and TRAF6), leading to the activation of
ranscription factors that bind to the IFN-β enhancer.
sing RNA interference to knock down gene expres-
ion, Seth et al. report that MAVS is not required for
RIF-mediated IFN-b gene expression, whereas Xu et
l. show that TRIF-induced IRF3 activation does require
AVS. Xu et al. also show an interaction between en-
ogenous TRIF and MAVS and demonstrate that TLR3-
nduced signaling is partially impaired in the absence
f MAVS. Resolution of this discrepancy is important
ecause if in fact MAVS is in the TLR3 pathway, bifurca-
ion of both pathways would occur at the level of MAVS.
ouse knockout studies will be required to unambigu-
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647ously determine whether MAVS is involved in TLR3 sig-
naling.
Although much work is required to fully describe the
MAVS-dependent signaling pathways, the identification
of MAVS and its mitochondrial localization is a major
advance in our understanding of the intracellular detec-
tion of viral infection. The fact that mitochondria may
be important in innate immunity hints at the possibility
of a direct link between viral infection and the regula-
tion of apoptosis. In fact, preliminary studies by Seth et
al. show that knockdown of MAVS gene expression by
small interfering RNAs leads to an increase in apopto-
sis. Thus, MAVS could protect cells from apoptosis dur-
ing the early stages of viral infection, maximizing the
production of cytokines from the infected cell. In any
case, these exciting new findings highlight the central
part played by mitochondria in balancing the host im-
mune response and programmed cell death response
to virus and possibly to other pathogens.
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Note Added in Proof
While this preview was in press, a related article appeared online
(Kawai et al., 2005, Nat. Immunol., doi: 10.1038/ni1243). This article
also reports the identification of MAVS (which the authors named
IPS-1). Consistent with the studies featured here, IPS-1/MAVS is
required for RIG-1 and Mda5-dependent induction of IFN-b gene
expression. In addition, IPS-1/MAVS binds to RIG-1 and Mda5 as
well as to both RIP1 and FADD. Finally, overexpression of domi-
nant-negative FADD blocks IPS-1/MAVS-dependent expression of
an NF-κB reporter gene, thus providing evidence that RIP1 and
FADD mediate the activation of NF-κB through the RIG-1 pathway.
DOI 10.1016/j.cell.2005.08.026
